Evidence map›Paper›PMID 32988817›Full record

ArticleAntimicrobial agents and chemotherapy2020

A Cross-Sectional Cohort Study of Extended-Spectrum-Beta-Lactamase-Producing

Oskar Ljungquist, Angela Camporeale, Shoeib Nematzadeh, Christian G Giske, Fredrik Resman, Kristian Riesbeck, Johan Tham

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Prevalence of CTX-M types among ESBL-producing pathogenicFood science and biotechnology · 2024
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oskar LjungquistClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden oskar.ljungquist@med.lu.se.ORCID 0000-0003-2951-1309
Angela CamporealeDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0001-6294-4996
Shoeib NematzadehDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Christian G GiskeDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Fredrik ResmanClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Kristian Riesbeck *Clinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Johan Tham *Clinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with traveler's diarrhea (TD) can acquire extended-spectrum-beta-lactamase (ESBL)-producing members of the

Indexed as

Escherichia coliEscherichia coli InfectionsAnti-Bacterial Agentsbeta-LactamasesCross-Sectional StudiesDiarrheaHumansSwedenTravelAnti-Bacterial Agentsbeta-Lactamasesbeta-lactamasesE. coliESBLpAmpC

Identifiers

PMID32988817
PMCPMC7674057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.